With the increase in molecular diagnostics available for UTI testing, there are concerns that the increased sensitivity may lead to overtreatment and increase in antibiotic resistance. The study compared antibiotic resistance results at different points in time in patients with UTIs who were either treated based on Guidance ® UTI testing or who were not treated with antibiotics. Separately, data published in the peer-reviewed journal Infection and Drug Resistance suggests that treatment based upon Guidance ® UTI testing resulted in reduced antibiotic resistance in symptomatic patients with suspected complicated UTIs. In addition, results showed patients diagnosed via the Guidance ® test had improved outcomes, including fewer inpatient episodes and lower inpatient costs. In fact, average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance ® test than for those based on the traditional culture test. Real-world evidence published in the JU Open Plus revealed that patients suffering from recurrent or complicated UTIs who were diagnosed with the Guidance ® UTI test experienced reduced clinical care and utilization costs related to their UTIs compared with patients diagnosed through standard urine culture (SUC) tests. The studies show that treatment based on the company's Guidance ® UTI test resulted in decreased health care resource utilization and costs compared to standard urine culture (SUC) tests, as well as reduced antibiotic resistance in patients with complicated urinary tract infections. IRVINE, Calif., J/PRNewswire/ - Pathnostics, a leading precision diagnostic testing and development company, today announced the publication of two new studies demonstrating positive outcomes resulting from its advanced urinary tract infection (UTI) test. These two studies featured in peer-reviewed publications are the first of many data milestones anticipated this year for advanced UTI testing Separately, data published in Infection and Drug Resistance suggests treatment based upon Guidance ® UTI test resulted in reduced antibiotic resistance Studies Show Reduced Health Care Costs, Utilization & Antibiotic Resistance in Patients Diagnosed & Treated with Advanced TestingĪ study published in the JU Open Plus shows real-world evidence of decreased UTI-related costs and improved outcomes for patients diagnosed and treated with Pathnostics' advanced Guidance ® UTI test vs.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |